Comments on: Roches’ Tamiflu May Not Be So Useful, After All http://www.pharmalot.com/2009/12/roches-tamiflu-may-not-be-so-useful-after-all/ News, Comment and Conversation Fri, 10 Feb 2012 22:44:50 +0000 http://wordpress.org/?v=2.6.2 By: patrons99 http://www.pharmalot.com/2009/12/roches-tamiflu-may-not-be-so-useful-after-all/#comment-452464 patrons99 Sat, 19 Dec 2009 14:31:16 +0000 http://www.pharmalot.com/?p=20323#comment-452464 Maybe the wolf is at the door...the hemorhagic pneumonic plague in the Ukraine. You wouldn’t know it from the mainstream media, CDC, WHO, EMEA, and FDA, however. Over a million infected. About 500 deaths. See also David Phillips BNET article of December 16th, titled “Efficacy of Roche’s Flu Drug Tamiflu in Doubt”. http://industry.bnet.com/pharma/10005827/efficacy-of-roches-flu-drug-tamiflu-in-doubt/ Here’s another recent article that may be of interest to your readers and might bear on the efficacy (or lack of efficacy) of Roche’s Tamiflu. From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge? Virology Journal 2009, 6:207 doi:10.1186/1743-422X-6-207 Adrian J Gibbs (adrian_j_gibbs@hotmail.com) John S Armstrong (j_s_armstrong@hotmail.com) Jean C Downie (jean.downie@bigpond.com.au) Publication date 24 November 2009 Article URL http://www.virologyj.com/content/6/1/207 "The possibility that human activity may have had some role in its (the swine flu virus) origins should not be dismissed without a dispassionate analysis of all available evidence," the paper states. Maybe the wolf is at the door…the hemorhagic pneumonic plague in the Ukraine. You wouldn’t know it from the mainstream media, CDC, WHO, EMEA, and FDA, however. Over a million infected. About 500 deaths. See also David Phillips BNET article of December 16th, titled “Efficacy of Roche’s Flu Drug Tamiflu in Doubt”.

http://industry.bnet.com/pharma/10005827/efficacy-of-roches-flu-drug-tamiflu-in-doubt/

Here’s another recent article that may be of interest to your readers and might bear on the efficacy (or lack of efficacy) of Roche’s Tamiflu.

From where did the 2009 ’swine-origin’ influenza A virus (H1N1) emerge?
Virology Journal 2009, 6:207 doi:10.1186/1743-422X-6-207
Adrian J Gibbs (adrian_j_gibbs@hotmail.com)
John S Armstrong (j_s_armstrong@hotmail.com)
Jean C Downie (jean.downie@bigpond.com.au)

Publication date 24 November 2009
Article URL http://www.virologyj.com/content/6/1/207

“The possibility that human activity may have had some role in its (the swine flu virus)
origins should not be dismissed without a dispassionate analysis of all available
evidence,” the paper states.

]]> By: harpy http://www.pharmalot.com/2009/12/roches-tamiflu-may-not-be-so-useful-after-all/#comment-450447 harpy Wed, 09 Dec 2009 19:49:49 +0000 http://www.pharmalot.com/?p=20323#comment-450447 Will we still believe them when the wolf is really at the door? Will we still believe them when the wolf is really at the door?

]]> By: Evelyn Pringle http://www.pharmalot.com/2009/12/roches-tamiflu-may-not-be-so-useful-after-all/#comment-450437 Evelyn Pringle Wed, 09 Dec 2009 19:03:36 +0000 http://www.pharmalot.com/?p=20323#comment-450437 A story I read by Bloomberg said Roche expected to make over $2 billion this year off Tamiflu. It also mentioned that less than 9,000 people worldwide had died from the swine flu since April. Considering that the world population is about 6.7 billion, I'd say we got bilked big time by the vaccine makers via the swine flu profiteering scheme but not without the helping hand of our government officials. A story I read by Bloomberg said Roche expected to make over $2 billion this year off Tamiflu.

It also mentioned that less than 9,000 people worldwide had died from the swine flu since April.

Considering that the world population is about 6.7 billion, I’d say we got bilked big time by the vaccine makers via the swine flu profiteering scheme but not without the helping hand of our government officials.

]]> By: harpy http://www.pharmalot.com/2009/12/roches-tamiflu-may-not-be-so-useful-after-all/#comment-450375 harpy Wed, 09 Dec 2009 15:08:10 +0000 http://www.pharmalot.com/?p=20323#comment-450375 This story seems to go right to the heart of the debate over company-funded studies and registering clinical trials. Very informative. This story seems to go right to the heart of the debate over company-funded studies and registering clinical trials. Very informative.

]]> By: patrons99 http://www.pharmalot.com/2009/12/roches-tamiflu-may-not-be-so-useful-after-all/#comment-450362 patrons99 Wed, 09 Dec 2009 14:19:41 +0000 http://www.pharmalot.com/?p=20323#comment-450362 It's not just efficacy that's at issue with the neuraminidase inhibitors. There have been a fairly large number of associated neuropsychiatric side effects reported, including amnesia. I don't believe that safety in pregnancy has been established. Let's pray it doesn't prove to be teratogenic. It’s not just efficacy that’s at issue with the neuraminidase inhibitors. There have been a fairly large number of associated neuropsychiatric side effects reported, including amnesia. I don’t believe that safety in pregnancy has been established. Let’s pray it doesn’t prove to be teratogenic.

]]>